Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins-Reference-Cited by-同舟云学术

Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins

Published:2022-04-11 Issue:10 Volume:82 Page:1005-1015
ISSN:0270-4137
Container-title:The Prostate
language:en
Short-container-title:The Prostate

Author:

Mori Joakin O.¹,Shafran Jordan S.¹,Stojanova Marija¹,Katz Mark H.²,Gignac Gretchen A.¹,Wisco Jonathan J.³,Heaphy Christopher M.¹⁴^ORCID,Denis Gerald V.¹

Affiliation:

1. Section of Hematology and Medical Oncology Boston University School of Medicine and Boston Medical Center Boston Massachusetts USA

2. Department of Urology Boston University School of Medicine Boston Massachusetts USA

3. Department of Anatomy and Neurobiology Boston University School of Medicine Boston Massachusetts USA

4. Department of Pathology and Laboratory Medicine Boston University School of Medicine Boston Massachusetts USA

Publisher

Wiley

Subject

Urology,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pros.24351

Reference109 articles.

1. Gene Polymorphism-related Individual and Interracial Differences in the Outcomes of Androgen Deprivation Therapy for Prostate Cancer

2. A prospective clinical and transcriptomic feasibility study of oral‐only hormonal therapy with radiation for unfavorable prostate cancer in men 70 years of age and older or with comorbidity

3. Predictors of early androgen deprivation treatment failure in prostate cancer with bone metastases

4. Concurrent diabetes mellitus may negatively influence clinical progression and response to androgen deprivation therapy in patients with advanced prostate cancer;Shevach J;Front Oncol,2015

5. Molecular regulation of androgen action in prostate cancer

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical efficacy of different androgen deprivation therapies for prostate cancer and evaluation based on dynamic-contrast enhanced magnetic resonance imaging;Acta Biochimica Polonica;2024-05-15

2. Overcoming chemoresistance and radio resistance in prostate cancer: The emergent role of non-coding RNAs;Pathology - Research and Practice;2024-03

3. Transforming lung cancer types;Science;2024-02-09

4. Prognostic and therapeutic potential of senescent stromal fibroblasts in prostate cancer;Nature Reviews Urology;2023-10-31

5. Rational design, synthesis and biological evaluation of benzo[d]isoxazole derivatives as potent BET bivalent inhibitors for potential treatment of prostate cancer;Bioorganic Chemistry;2023-06